Effect of timing of treatment of the glyburide-reversible cardioprotective activity of BMS-180448

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 24-33

  Gomoll, Allen W ^a   Roth, Russell A ^a   Swillo, Robert E ^a   Baird, Anne J ^a   Sargent, Carol S ^a   Behling, Ronald W ^b   Malone, Harold J ^b   Grover, Gary J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMAKALIM; CALCIUM ION; CROMAKALIM; N (4 CHLOROPHENYL) N' CYANO N'' (6 CYANO 3,4 DIHYDRO 3 HYDROXY 2,2 DIMETHYL 2H 1 BENZOPYRAN 4 YL)GUANIDINE; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; FERRET; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; BENZOPYRANS; CALCIUM; FERRETS; GLYBURIDE; GUANIDINES; HEART; MALE; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNELS; RATS; TIME FACTORS;

EID: 0030998331     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ATP channels and preconditioning of rabbit cardiomyocytes (abstract). J. Mol. Cell. Cardiol. 27: A23, 1995.
2. ATWAL, K. S., GROVER, G. J., AHMED, S. Z., FERRARA, F. N., HARPER, T. W., KIM, Y. S., SLEPH, P. G., DWZWONCZYK, S., RUSSELL, A. D., MORELAND, S., McCULLOUGH, J. R. AND NORMANDIN, D. E.: Cardioselective anti-ischemic ATP-sensitive potassium channel openers. J. Med. Chem. 36: 3971-3974, 1993.
3. ATWAL, K. S., GROVER, G. J., FERRARA, F. N., AHMED, S. Z., SLEPH, P. G., DZWONCZYK, S. AND NORMANDIN, D. E.: Cardioselective antiischemic ATPsensitive potassium channel openers. 2. Structure-activity studies on benzopyranyl-cyanoguanidines: modification of the benzopyran ring. J. Med. Chem. 38: 1966-1973, 1995.
4. + channel opener aprikalim (RP 52891) reduced experimental infarct size in dogs in the absence of hemodynamic changes. J. Pharmacol. Exp. Ther. 259: 961-967, 1991.
5. ATP opener BMS-180448 on ischemic/reperfused myocardial function and energetics (abstract). FASEB J. 10: A319, 1996.
6. ATP-channel openers protect against increased cytosolic calcium during ischemia and reperfusion. J. Mol. Cell. Cardiol. 27: 1809-1817, 1995.
7. + channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69: 571-581, 1991.
8. D'ALONZO, A. J., DARBENZIO, R. B., PARHAM, C. S. AND GROVER, G. J.: Effects of intracoronary cromakalim on postischemic contractile function and action potential duration. Cardiovasc. Res. 26: 1046-1053, 1992.
9. ENDO, T., NEJIMA, J., KIUCHI, K., FUJITA, S., KIKUCHI, K., HAYAKAWA, H. AND OKUMURA. H.: Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs. J. Cardiovasc. Pharmacol. 12: 587-592, 1988.
10. FLAIM, S. F., NELLIS, S. H., TOGGART, E. J., DREXLER, H., KANDA, K. AND NEWMAN, E D.: Multiple simultaneous determinations of hemodynamics and flow distribution in conscious rat. J. Pharmacol. Meth. 11: 1-39, 1984.
11. GOMOLL, A. W., GROVER, G. J. AND OGLETREE, M. L.: Myocardial salvage efficacy of the thromboxane receptor antagonist ifetroban in ferrets and dogs. J. Cardiovasc. Pharmacol. 24: 960-968, 1994.
12. GROSS, G. J., AUCHAMPACH, J. A., MARUYAMA, M., WARLTIER, D. C. AND PIEPER, G. M.: Cardioprotective effects of nicorandil. J. Cardiovasc. Pharmacol. 20: suppl. 3, S22-S28, 1992.
13. ATP openers in models of myocardial ischemia and reperfusion. Can. J. Physiol. Pharmacol., in press. 1997.
14. GROVER, G. J., D'ALONZO, A. J., HESS, T., SLEPH, P. G. .AND DARBENZIO, R. B.: Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc. Res. 30: 731-738, 1995a.
15. GROVER, G. J., DZWONCZYK, S., PARHAM, C. S. AND SLEPH, P. G.: The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc. Drugs Ther. 4: 465-474, 1990a.
16. GROVER, G. J., DZWONCZYK, S. AND SLEPH, P. G.: Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891. Eur. J. Pharmacol. 191: 11-18, 1990b.
17. GROVER, G. J., McCULLOUGH, J. R., D'ALONZO, A. J., SARGENT, C. A. AND ATWAL, K. S.: Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. J. Cardiovasc. Pharmacol. 25: 40-50, 1995b.
18. GROVER, G. J., PARHAM, C. S., WHIGAN, D. B. AND MITROKA, J. G.: BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile dysfunction in dogs. J. Pharmacol. Exp. Ther. 276: 380-387, 1996.
19. ATP openers in ischemic rat hearts treated with a potassium cardioplegic solution. J. Cardiovasc. Pharmacol. 26: 698-706, 1995.
20. GROVER, G. J., SLEPH, P. G. AND DZWONCZYK, S.: Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J. Cardiovasc. Pharmacol. 16: 853-864, 1990c.
21. GROVER, G. J., SLEPH, P. G., DZWONCZYK, S., MALONE, H. J. AND BEHLING, R. W.: Glyburide-reversible cardioprotective effects of BMS-180448: Functional and energetic considerations. J. Cardiovasc. Pharmacol., in press, 1997.
22. HEYMANN, M. A., PAYNE, B. D., HOFFMAN, J. I. E. AND RUDOLPH, A. M.: Blood flow measurements with radionuclide-labeled particles. Prog. Cardiovasc. Dis. 20: 55-79, 1977.
23. + channel in the mitochondrial inner membrane. Nature (Lond.). 352: 244-247, 1991.
24. MARBAN, E., KITAKAZE, M., KUSUOKA, H., PORTERFIELD, J. K., YUE, D. T. AND CHACKO, V. P.: Intracellular free calcium concentration measured with 19F NMR spectroscopy in intact ferret hearts. Proc. Natl. Acad. Sci. U.S.A. 84: 6005-6009, 1987.
25. McCULLOUGH, J. R., NORMANDIN, D. E., CONDER, M. L., SLEPH, P. G., DZWONCZYK, S. AND GROVER, G. J.: Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ. Res. 69: 949-958, 1991.
26. + channels involves high-energy phosphate preservation. Am. J. Physiol. 265: H1809-H1818, 1993.
27. MITANI, A., KINOSHITA, K., FUKAMACHI, K., SAKAMOTO, M., KURISU, K., TSURUHARA, Y., FUKUMARA, F., NAKASHIMA, A. AND TOKUNAGA, K.: Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts. Am. J. Physiol. 261: H1864-H1871, 1991.
28. MIZUMURA, T., NITHIPATIKOM, K. AND GROSS, G. J.: Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation. 92: 1236-1245, 1995.
29. MONTICELLO, T. M., SARGENT, C. A., McGILL, J. R., BAARTON, D. S. AND GROVER, G. J.: Amelioration of ischemia/reperfusion injury in isolated rat hearts by the ATP-sensitive potassium channel opener BMS-180448. Cardiovasc. Res. 31: 93-101, 1996.
30. OHTA, H., JINNO, Y., HARADA, K., OGAWA, N., FUKUSHIMA, H. AND NISHIKORI, K.: Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. Eur. J. Pharmacol. 204: 171-177, 1991.
31. ATP channel (abstract). Biophys. J. 68: A145, 1995.
32. PIEPER, G. M. AND GROSS, G. J.: EMD 52692 (bimakalim), a new potassium channel opener, attenuates luminol-enhanced chemiluminescence and superoxide anion radical formation by zymosan-activated polymorphonuclear leukocytes. Immunopharmacology 23: 191-197, 1992.
33. POOLE-WILSON, P. A., HARDING, D. P., BOURDELLON, P. D. V. AND JONES, M. A.: Calcium out of control. J. Mol. Cell. Cardiol. 16: 175-187, 1984.
34. ROHMANN, S., WEYGANDT, H., SCHELLING, P., KIE-SOEL, L., VERDOUW, P. D. AND LUES, I.: Involvement of ATP-sensitive potassium channels in preconditioning protection. Basic Res. Cardiol. 89: 563-576, 1994.
35. WESELCOUCH, E. O., BAIRD, A. J., SMITH, M. A. AND GOMOLL, A. W.: Effect of BMS-180448 and cromakalim on regional blood flow in the heart and brain of anesthetized dogs and ferrets (abstract). FASEB J. 8: A292, 1994.
36. WOERKENS, L. J. v., BAAS, N. R. A., GIESSEN, W. J. v. D. AND VERDOUW, P. D.: Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil. Cardiovase. Drug Ther. 6: 409-417, 1992.